336 related articles for article (PubMed ID: 31947710)
1. Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes.
Valle-Mendiola A; Soto-Cruz I
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947710
[TBL] [Abstract][Full Text] [Related]
2. STAT proteins in cancer: orchestration of metabolism.
Li YJ; Zhang C; Martincuks A; Herrmann A; Yu H
Nat Rev Cancer; 2023 Mar; 23(3):115-134. PubMed ID: 36596870
[TBL] [Abstract][Full Text] [Related]
3. STAT proteins as novel targets for cancer drug discovery.
Turkson J
Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
[TBL] [Abstract][Full Text] [Related]
4. Involvement of STAT5 in Oncogenesis.
Halim CE; Deng S; Ong MS; Yap CT
Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32872372
[TBL] [Abstract][Full Text] [Related]
5. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.
Clarkson RW; Boland MP; Kritikou EA; Lee JM; Freeman TC; Tiffen PG; Watson CJ
Mol Endocrinol; 2006 Mar; 20(3):675-85. PubMed ID: 16293640
[TBL] [Abstract][Full Text] [Related]
6. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.
Wingelhofer B; Neubauer HA; Valent P; Han X; Constantinescu SN; Gunning PT; Müller M; Moriggl R
Leukemia; 2018 Aug; 32(8):1713-1726. PubMed ID: 29728695
[TBL] [Abstract][Full Text] [Related]
7. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
[TBL] [Abstract][Full Text] [Related]
8. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2002 Feb; 143(2):492-503. PubMed ID: 11796503
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells.
Anderson P; Sundstedt A; Li L; O'Neill EJ; Li S; Wraith DC; Wang P
Int Immunol; 2003 Nov; 15(11):1309-17. PubMed ID: 14565929
[TBL] [Abstract][Full Text] [Related]
10. Cell Metabolism Control Through O-GlcNAcylation of STAT5: A Full or Empty Fuel Tank Makes a Big Difference for Cancer Cell Growth and Survival.
Rauth M; Freund P; Orlova A; Grünert S; Tasic N; Han X; Ruan HB; Neubauer HA; Moriggl R
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818760
[TBL] [Abstract][Full Text] [Related]
11. Oxidative metabolism in cancer: A STAT affair?
Bourgeais J; Gouilleux-Gruart V; Gouilleux F
JAKSTAT; 2013 Oct; 2(4):e25764. PubMed ID: 24416651
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
14. EGF promotes HIF-1α expression in colorectal cancer cells and tumor metastasis by regulating phosphorylation of STAT3.
Zhao FL; Qin CF
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1055-1062. PubMed ID: 30779072
[TBL] [Abstract][Full Text] [Related]
15. Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model.
Kim C; Lee SG; Yang WM; Arfuso F; Um JY; Kumar AP; Bian J; Sethi G; Ahn KS
Cancer Lett; 2018 Sep; 431():123-141. PubMed ID: 29857127
[TBL] [Abstract][Full Text] [Related]
16. STAT3 and STAT5 Activation in Solid Cancers.
Igelmann S; Neubauer HA; Ferbeyre G
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31557897
[TBL] [Abstract][Full Text] [Related]
17. STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line.
Granillo AR; Boffi JC; Barañao L; Kordon E; Pecci A; Guberman A
Biochem Biophys Res Commun; 2007 May; 356(3):727-32. PubMed ID: 17382296
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal effects of STAT5 and STAT3 in breast cancer.
Walker SR; Nelson EA; Zou L; Chaudhury M; Signoretti S; Richardson A; Frank DA
Mol Cancer Res; 2009 Jun; 7(6):966-76. PubMed ID: 19491198
[TBL] [Abstract][Full Text] [Related]
19. Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation.
Dong B; Liang Z; Chen Z; Li B; Zheng L; Yang J; Zhou H; Qu L
Sci China Life Sci; 2018 Sep; 61(9):999-1009. PubMed ID: 30054832
[TBL] [Abstract][Full Text] [Related]
20. STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications.
Tošić I; Frank DA
Neoplasia; 2021 Dec; 23(12):1167-1178. PubMed ID: 34731785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
